214 related articles for article (PubMed ID: 18951447)
41. Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes.
Shirts BH; Jacobson A; Jarvik GP; Browning BL
Genet Med; 2014 Jul; 16(7):529-34. PubMed ID: 24357849
[TBL] [Abstract][Full Text] [Related]
42. Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes.
Pesaran T; Karam R; Huether R; Li S; Farber-Katz S; Chamberlin A; Chong H; LaDuca H; Elliott A
Int J Breast Cancer; 2016; 2016():2469523. PubMed ID: 27822389
[TBL] [Abstract][Full Text] [Related]
43. Variants of Uncertain Significance and "Missing Pathogenicity".
Fatkin D; Johnson R
J Am Heart Assoc; 2020 Feb; 9(3):e015588. PubMed ID: 32009523
[No Abstract] [Full Text] [Related]
44. What Is a Variant of Uncertain Significance in Genetic Testing?
Nicolosi P; Heald B; Esplin ED
Eur Urol Focus; 2022 May; 8(3):654-656. PubMed ID: 35422376
[TBL] [Abstract][Full Text] [Related]
45. Are Functional Assays for Pathogenicity Assessment of Genetic Variants Overrated?
Sobrido MJ
Hum Mutat; 2017 Jan; 38(1):5. PubMed ID: 27943540
[No Abstract] [Full Text] [Related]
46. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice.
Hoffman-Andrews L
J Law Biosci; 2017 Dec; 4(3):648-657. PubMed ID: 29868193
[No Abstract] [Full Text] [Related]
47. Understanding genetic variants of uncertain significance.
Joynt ACM; Axford MM; Chad L; Costain G
Paediatr Child Health; 2022 Mar; 27(1):10-11. PubMed ID: 35273666
[No Abstract] [Full Text] [Related]
48. Removing uncertainty from variants of unknown significance.
McNally EM
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317969
[No Abstract] [Full Text] [Related]
49. Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome.
Nolano A; Medugno A; Trombetti S; Liccardo R; De Rosa M; Izzo P; Duraturo F
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612072
[TBL] [Abstract][Full Text] [Related]
50. Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin.
Gervas P; Molokov A; Babyshkina N; Kiselev A; Zarubin A; Yumov E; Pisareva L; Choynzonov E; Cherdyntseva N
Asian Pac J Cancer Prev; 2022 Jun; 23(6):2027-2033. PubMed ID: 35763645
[TBL] [Abstract][Full Text] [Related]
51. Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology.
Malhotra H; Kowtal P; Mehra N; Pramank R; Sarin R; Rajkumar T; Gupta S; Bapna A; Bhattacharyya GS; Gupta S; Maheshwari A; Mannan AU; Reddy Kundur R; Sekhon R; Singhal M; Smruti BK; Sp S; Suryavanshi M; Verma A
JCO Glob Oncol; 2020 Jul; 6():991-1008. PubMed ID: 32628584
[TBL] [Abstract][Full Text] [Related]
52. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers.
Federici G; Soddu S
J Exp Clin Cancer Res; 2020 Mar; 39(1):46. PubMed ID: 32127026
[TBL] [Abstract][Full Text] [Related]
53. The
Arason A; Agnarsson BA; Johannesdottir G; Johannsson OT; Hilmarsdottir B; Reynisdottir I; Barkardottir RB
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683985
[TBL] [Abstract][Full Text] [Related]
54. Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes.
Shirts BH; Konnick EQ; Upham S; Walsh T; Ranola JMO; Jacobson AL; King MC; Pearlman R; Hampel H; Pritchard CC
Am J Hum Genet; 2018 Jul; 103(1):19-29. PubMed ID: 29887214
[TBL] [Abstract][Full Text] [Related]
55. Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.
Yang C; Jairam S; Amoroso KA; Robson ME; Walsh MF; Zhang L
Breast Cancer Res Treat; 2018 Apr; 168(2):543-550. PubMed ID: 29185120
[TBL] [Abstract][Full Text] [Related]
56.
Borras E; Chang K; Pande M; Cuddy A; Bosch JL; Bannon SA; Mork ME; Rodriguez-Bigas MA; Taggart MW; Lynch PM; You YN; Vilar E
Cancer Prev Res (Phila); 2017 Oct; 10(10):580-587. PubMed ID: 28765196
[TBL] [Abstract][Full Text] [Related]
57. Microsatellite instability use in mismatch repair gene sequence variant classification.
Thompson BA; Spurdle AB
Genes (Basel); 2015 Mar; 6(2):150-62. PubMed ID: 25831438
[TBL] [Abstract][Full Text] [Related]
58. Genetic predisposition to colorectal cancer: where we stand and future perspectives.
Valle L
World J Gastroenterol; 2014 Aug; 20(29):9828-49. PubMed ID: 25110415
[TBL] [Abstract][Full Text] [Related]
59. The Clinical Significance of Unknown Sequence Variants in BRCA Genes.
Calò V; Bruno L; La Paglia L; Perez M; Margarese N; Di Gaudio F; Russo A
Cancers (Basel); 2010 Sep; 2(3):1644-60. PubMed ID: 24281179
[TBL] [Abstract][Full Text] [Related]
60. Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.
Farrell MP; Hughes DJ; Drost M; Wallace AJ; Cummins RJ; Fletcher TA; Meany MA; Kay EW; de Wind N; Power DG; Andrews EJ; Green AJ; Gallagher DJ
Fam Cancer; 2013 Dec; 12(4):741-7. PubMed ID: 23712482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
